TANG Capital Partners L.P., Chief Financial Officer, Chief Executive Officer, 10% Owner, Officer at Odonate Therapeutics, Inc. (ODT), bought 29,230 shares at $15.15 ($447K) on 2018-11-21, disclosed to the SEC on 2018-11-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.15 | 5,356 | $81K | 18.1% |
| 2 | $15.15 | 5,356 | $81K | 18.1% |
| 3 | $15.25 | 4,644 | $71K | 15.8% |
| 4 | $15.43 | 6,937 | $107K | 23.9% |
| 5 | $15.43 | 6,937 | $107K | 23.9% |
| Total | $15.30 avg | 29,230 |
| $447K |
| 100% |
| Filing → |
| TCRR | BUY | 2023-05-10 | $275K | — | Filing → |
| TCRR | BUY | 2023-05-05 | $1.1M | — | Filing → |
| LJPC | SELL | 2021-12-01 | $3.4M | — | Filing → |